SCHEMBL7064359

SCHEMBL7064359

CCSSc1ncc[nH]1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31202896 0.84 TXN (0.54)
SCHEMBL5551187 0.81 TXN (0.51)
SCHEMBL3503342 0.79 TXN (0.55)
SCHEMBL22341497 0.79
SCHEMBL5343833 0.78
SCHEMBL21331975 0.78 TXN (0.49)
SCHEMBL18321824 0.78 TXN (0.49)
SCHEMBL2812932 0.75 TXN (0.45)
Px-12 SCHEMBL775481 0.73 TXN (1.00)
SCHEMBL4190883 0.72 TAAR1 (0.47)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250108036-A1 COMPOSITIONS FOR REMOVING SENESCENT CELLS AND USES THEREOF LIFECEUTIX CO., LTD. (KR) 2025-04-03 US disclosed
US-20030176512-A1 Asymmetric disulfides and methods of using same PROLX PHARMACEUTICALS CORPORATION (CA) 2003-09-18 US disclosed
US-6552060-B1 Inhibits abnormal cellular proliferation and restores or prevents inhibition of cellular apoptosis PROLX PHARMACEUTICALS, INC. 2003-04-22 US disclosed